GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citi Pharma Ltd (KAR:CPHL) » Definitions » Sale Of Business

Citi Pharma (KAR:CPHL) Sale Of Business : ₨ Mil (TTM As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is Citi Pharma Sale Of Business?

Citi Pharma's sale of business for the six months ended in . 20 was ₨0.00 Mil. It means Citi Pharma gained ₨0.00 Mil from selling business. Citi Pharma does not have enough years/quarters to calculate the sale of business for the trailing twelve months (TTM) ended in . 20.

Compared with last quarter (₨0.00 Mil in . 20 ), Citi Pharma gained the same money from selling business in . 20 (₨0.00 Mil).


Citi Pharma Sale Of Business Historical Data

The historical data trend for Citi Pharma's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citi Pharma Sale Of Business Chart

Citi Pharma Annual Data
Trend
Sale Of Business

Citi Pharma Semi-Annual Data
Sale Of Business

Citi Pharma Sale Of Business Calculation

The amount earned to sell business.



Citi Pharma Sale Of Business Related Terms

Thank you for viewing the detailed overview of Citi Pharma's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Citi Pharma Business Description

Traded in Other Exchanges
N/A
Address
588 Q Block, Johar Town, Lahore, PB, PAK
Citi Pharma Ltd is engaged in the manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. Its departments include Active Pharma Ingredients (API) and Formulations. Some of its products include Askprol C Tab, Lenon Tab, Recoz Tab, Cingol Tab among others.

Citi Pharma Headlines

No Headlines